Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

PET technique promises better detection and response assessment for Non-Hodgkin's lymphoma

PET technique promises better detection and response assessment for Non-Hodgkin's lymphoma

Autologous stem cell transplantation does not improve overall survival in patients with follicular lymphoma

Autologous stem cell transplantation does not improve overall survival in patients with follicular lymphoma

ASH 2011: New drug data for managing rare blood cancers and conditions

ASH 2011: New drug data for managing rare blood cancers and conditions

ASH 2011: Study of two sisters sheds light on lymphoma evolution

ASH 2011: Study of two sisters sheds light on lymphoma evolution

ASH 2011: Donor T-Cells results in excellent relapse-free survival

ASH 2011: Donor T-Cells results in excellent relapse-free survival

ASH 2011: Over-expression of TRAIL on donor T-cells enhances GVT and suppresses GVHD

ASH 2011: Over-expression of TRAIL on donor T-cells enhances GVT and suppresses GVHD

ASH 2011: Bruton’s tyrosine kinase inhibitor induces durable responses in relapsed leukaemia and lymphoma

ASH 2011: Bruton’s tyrosine kinase inhibitor induces durable responses in relapsed leukaemia and lymphoma

ASH 2011: Randomized phase II trial comparing GA101 with rituximab

ASH 2011: Randomized phase II trial comparing GA101 with rituximab

ASH 2011: Final analysis of a randomised comparison of ABVD chemotherapy with radiation therapy

ASH 2011: Final analysis of a randomised comparison of ABVD chemotherapy with radiation therapy

ASH 2011: Cereblon expression is required for the anti-myeloma activity of lenalidomide and pomalidomide

ASH 2011: Cereblon expression is required for the anti-myeloma activity of lenalidomide and pomalidomide

More from ecancer